Targeting of a novel Ca2+/calmodulin-dependent protein kinase II is essential for extracellular signal-regulated kinase-mediated signaling in differentiated smooth muscle cells

Circulation Research

Volumn 97, Issue 6, 2005, Pages 541-549

  Marganski, William A ^a   Gangopadhyay, Samudra S ^a   Je, Hyun Dong ^a   Gallant, Cynthia ^a   Morgan, Kathleen G ^a,b  

^a BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CaMKII; Contractility; Extracellular signal regulated kinase; Smooth muscle; Targeting

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROLINE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CENTRIFUGATION; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME SPECIFICITY; FERRET; HUMAN; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; STIMULUS RESPONSE; TIME; TISSUE DISTRIBUTION;

ACTININ; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; COS CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FERRETS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; VASOCONSTRICTION; VIMENTIN;

EID: 25444526102     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000182630.29093.0d     Document Type: Article

References (41)

1. Hudmon A, Schulman H. Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II. Biochem J. 2002;364:593-611.
2. Yamauchi T, Fujisawa H. Evidence for three distinct forms of calmodulin-dependent protein kinases from rat brain. FEBS Lett. 1980;116:141-144.
3. Shen K, Meyer T. Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science. 1999;284:162-166.
4. Hudmon A, Schulman H. Neuronal Ca2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem. 2002;71:473-510.
5. Zhou ZL, Ikebe M. New isoforms of Ca2+/calmodulin-dependent protein kinase II in smooth muscle. Biochem J. 1994;299:489-495.
6. Kim I, Je HD, Gallant C, Zhan Q, Riper DV, Badwey JA, Singer HA, Morgan KG. Ca2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta. J Physiol. 2000;526(Pt 2):367-74.
7. Rokolya A, Singer HA. Inhibition of CaM kinase II activation and force maintenance by KN-93 in arterial smooth muscle. Am J Physiol Cell Physiol. 2000;278:C537-C545.
8. Bayer KU, Schulman H. Regulation of signal transduction by protein targeting: the case for CaMKII. Biochem Biophys Res Commun. 2001;289:917-923.
9. Colbran RJ. Targeting of calcium/calmodulin-dependent protein kinase II. Biochem J. 2004:378:1-16.
10. Gangopadhyay SS, Barber AL, Gallant C, Grabarek Z, Smith JL, Morgan KG. Differential functional properties of calmodulin-dependent protein kinase IIgamma variants isolated from smooth muscle. Biochem J. 2003;372:347-357.
11. Gangopadhyay SS, Takizawa N, Gallant C, Barber AL, Je HD, Smith TC, Luna EJ, Morgan KG. Smooth muscle archvillin: a novel regulator of signaling and contractility in vascular smooth muscle. J Cell Sci. 2004;117:5043-5057.
12. Eriksson JE, He T, Trejo-Skalli AV, Harmala-Brasfcen AS, Hellman J, Chou YH, Goldman RD. Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J Cell Sci. 2004;117:919-932.
13. Je HD, Gallant C, Leavis PC, Morgan KG. Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2004;286:H91-H98.
14. Abraham ST, Benscoter H, Schworer CM, Singer HA. A role for Ca2+/calmoduin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circ Res. 1997;81:575-584.
15. D'Angelo G, Graceffa P, Wang C-LA, Wrangle J, Adam LP. Mammal-specific, ERK-dependent, caldesmon phosphorylation in smooth muscle. J Biol Chem. 1999;274:30115-30121.
16. Nixon GF, Iizuka K, Haystead CMM, Haystead TAJ, Somlyo AP, Somlyo AV. Phosphorylation of caldesmon by mitogen-activated protein kinase with no effect on Ca2+ sensitivity in rabbit smooth muscle. J Physiol (Lond). 1995;487:283-289.
17. Gorenne I, Su X, Moreland RS. Inhibition of p42 and p44 MAP kinase does not alter smooth muscle contraction in swine carotid artery. Am J Physiol. 1998;44:H131-H138.
18. Hedges JC, Oxhorn BC, Carty M, Adam LP, Yamboliev IA, Gerthoffer WT. Phosphorylation of caldesmon by ERK MAP kinases in smooth muscle. Am J Physiol Cell Physiol. 2000;278:C718-C726.
19. Frank ED, Warren L. Aortic smooth muscle cells contain vimentin instead of desmin. Proc Natl Acad Sci U S A. 1981;78:3020-3024.
20. Bond M, Somlyo AV. Dense bodies and actin polarity in vertebrate smooth muscle. J Cell Biol. 1982;95:403-413.
21. Kuo KH, Herrera AM, Seow CY. Ultrastructure of airway smooth muscle. Respir Physiol Neurobiol. 2003;137:197-208.
22. Bagby R. Organization of contractile/cytoskeletal elements. In: Stephens NL, ed. Biochemistry of Smooth Muscle. Boca Raton, FL: CRC Press Inc; 1983:1-84.
23. Khalil RA, Morgan KG. PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle activation. Am J Physiol. 1993;265:C406-C411.
24. Small JV, Gimona M. The cytoskeleton of the vertebrate smooth muscle cell. Acta Physiol Scand. 1998;164:341-348.
25. North AJ, Galazkiewicz B, Byers TJ, Glenney JR Jr, Small JV. Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle. J Cell Biol. 1993;120:1159-1167.
26. Small JV. Geometry of actin-membrane attachments in the smooth muscle cell: the localisations of vinculin and alpha-actinin. EMBO J. 1985;4:45-49.
27. Ando S, Tokui T, Yamauchi T, Sugiura H, Tanabe K, Inagaki M. Evidence that Ser-82 is a unique phosphorylation site on vimentin for Ca2(+)-calmodulin-dependent protein kinase II. Biochem Biophys Res Commun. 1991;175:955-962.
28. Ogawara M, Inagaki N, Tsujimura K, Takai Y, Sekimata M, Ha MH, Imajoh-Ohmi S, Hirai S, Ohno S, Sugiura H, Yamauchi T, Inagaki M. Differential targeting of protein kinase C and CaM kinase II signalings to vimentin. J Cell Biol 1995;131:1055-1066.
29. Inagaki N, Goto H, Ogawara M, Nishi Y, Ando S, Inagaki M. Spatial patterns of Ca2+ signals define intracellular distribution of a signaling by Ca2+/Calmodulin-dependent protein kinase II. J Biol Chem. 1997;272:25195-25199.
30. Sin WC, Chen XQ, Leung T, Lim L. RhoA-binding kinase alpha translocation is facilitated by the collapse of the vimentin intermediate filament network. Mol Cell Biol. 1998;18:6325-6339.
31. Dhavan R, Greer PL, Morabito MA, Orlando LR, Tsai LH. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. J Neurosci. 2002;22:7879-7891.
32. Ginnan R, Singer HA. CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle. Am J Physiol Cell Physiol. 2002;282:C754-C761.
33. Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev. 1996;76:967-1003.
34. Dessy C, Kim I, Sougnez CL, Laporte R, Morgan KG. A role for MAP kinase in differentiated smooth muscle contraction evoked by a-adrenoceptor stimulation. Am J Physiol Cell Physiol. 1998;275: C1081-C1086.
35. Khalil RA, Menice CB, Wang C-LA, Morgan KG. Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ Res. 1995;76:1101-1108.
36. Lu KK, Armstrong SE, Ginnan R, Singer HA. Adhesion-dependent activation of CaM Kinase II and regulation of ERK activation in vascular smooth muscle. Am J Physiol Cell Physiol. 2005:June 15;Epub.
37. Sundberg-Smith LJ, Doherty JT, Mack CP, Taylor JM. Adhesion stimulates direct PAK1/ERK2 association and leads to ERK-dependent PAK1 Thr212 phosphorylation. J Biol Chem. 2005;280:2055-2064.
38. Lo IC, Shih JM, Jiang MJ. Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. J Biomed Sci. 2005;12:377-388.
39. Blaschke F, Stawowy P, Kappert K, Goetze S, Kintscher U, Wollen-Wulf B, Fleck E, Graf K. Angiotensin II-augmented migration of VSMCs towards PDGF-BB involves Pyk2 and ERK 1/2 activation. Basic Res Cardiol. 2002;97:334-342.
40. Lee JH, Johnson PR, Roth M, Hunt NH, Black JL. ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2001;280:L1019-L1029.
41. Yamboliev IA, Gerthoffer WT. Modulatory role of ERK MAPK-caldesmon pathway in PDGF-stimulated migration of cultured pulmonary artery SMCs. Am J Physiol Cell Physiol. 2001;280:C1680-C1688.